| Ident. | Authors (with country if any) | Title |
|---|
| 000010 |
YOUN JU LEE [Corée du Sud] ; So-Young Choi [Corée du Sud] ; Jae H. Yang [Corée du Sud] | NMDA receptor-mediated ERK 1/2 pathway is involved in PFHxS-induced apoptosis of PC12 cells |
| 000171 |
Tyler Bassett [Canada] ; Paxton Bach [Canada] ; Hing Man Chan [Canada] | Effects of methylmercury on the secretion of pro-inflammatory cytokines from primary microglial cells and astrocytes |
| 000255 |
Moonhee Lee [Canada] ; Nattinee Jantaratnotai [Canada] ; Edith Mcgeer [Canada] ; James G. Mclarnon [Canada] ; Patrick L. Mcgeer [Canada] | Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels |
| 000279 |
Ngoc-Duc Doan [Canada] ; Steve Bourgault [Canada] ; Agnieszka Dejda [Canada] ; Myriam Letourneau [Canada] ; Michel Detheux [Belgique] ; David Vaudry [Canada, France] ; Hubert Vaudry [Canada, France] ; David Chatenet [Canada] ; Alain Fournier [Canada] | Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects |
| 000480 |
Sandra Lourenssen [Canada] ; Kurtis G. Miller [Canada] ; Michael G. Blennerhassett [Canada] | Discrete responses of myenteric neurons to structural and functional damage by neurotoxins in vitro |
| 000630 |
K. V. Rama Rao [États-Unis] ; P. V. B. Reddy [États-Unis] ; A. S. Hazell [Canada] ; M. D. Norenberg [États-Unis] | Manganese induces cell swelling in cultured astrocytes |
| 000660 |
L. Borgal [Canada] ; M. Hong [Canada] ; D. Sadi [Canada] ; I. Mendez [Canada] | Differential effects of glial cell line-derived neurotrophic factor on A9 and A10 dopamine neuron survival in vitro |
| 000780 |
V. F. Rafuse [Canada] ; P. Soundararajan [Canada] ; C. Leopold [Canada] ; H. A. Robertson [Canada] | Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog |
| 000894 |
Sharmila Alam [Canada] ; Arindom Sen [Canada] ; Leo A. Behie [Canada] ; Michael S. Kallos [Canada] | Cell cycle kinetics of expanding populations of neural stem and progenitor cells in vitro |
| 000993 |
Vincenzo Di Matteo [Italie] ; Marisa Cacchio [Italie] ; Camillo Di Giulio [Italie] ; Ennio Esposito [Italie] | Role of serotonin2C receptors in the control of brain dopaminergic function |
| 000A11 |
I. Khabazian [Canada] ; J. S. Bains [Canada] ; D. E. Williams [Canada] ; J. Cheung [Canada] ; J. M. B. Wilson [Canada] ; B. A. Pasqualotto [Canada] ; S. L. Pelech [Canada] ; R. J. Andersen [Canada] ; Y.-T. Wang [Canada] ; L. Liu [Canada] ; A. Nagai [Canada] ; S. U. Kim [Canada] ; U-K. Craig ; C. A. Shaw [Canada] | Isolation of various forms of sterol β-d-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex |
| 000A12 |
Kristen J. Armstrong [Canada] ; Lennard P. Niles [Canada] | Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells |
| 000A21 |
Sophie Callier [France, Canada] ; Maryvonne Le Saux [France] ; Anne-Marie Lhiaubet [France] ; Thérèse Di Paolo [Canada] ; William Rostene [France] ; Didier Pelaprat [France] | Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture |
| 000A50 |
Wakako Maruyama [Japon] ; Yukihiro Akao [Japon] ; Moussa B. H. Youdim [Israël] ; Bruce A. Davis [Canada] ; Makoto Naoi [Japon] | Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol |
| 000B23 |
Michael Y. Oh [Canada] ; Mojgan Hodaie [Canada] ; SEONG HO KIM [Canada] ; Ahmed Alkhani [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; M. Aml ; Frank Hsu ; Kim J. Burchiel ; Patrick I. Kelly ; Roy A. E. Bakay ; Alon Mogilner | Deep brain stimulator electrodes used for lesioning: Proof of principle. Commentaries |
| 000B49 |
Hong Y. Choi [Canada] ; Jin H. Song [Canada] ; Dong K. Park [Corée du Sud] ; Gregory M. Ross [Canada] | The effects of ascorbic acid on dopamine-induced death of PC12 cells are dependent on exposure kinetics |
| 000B89 |
Maria C. Yang [Canada] ; Allan J. Mclean [Canada] ; Laurent P. Rivory [Australie] ; David G. Le Couteur [Canada] | Hepafic disposition of neurotoxins and pesticides |
| 000B96 |
M. Cyr [Canada] ; F. Calon [Canada] ; M. Morissette [Canada] ; M. Grandbois [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada] | Drugs with estrogen-like potency and brain activity : Potential therapeutic application for the CNS |
| 000C46 |
H. M. Schipper [Canada] ; L. Bernier [Canada] ; K. Mehindate [Canada] ; D. Frankel [Canada] | Mitochondrial iron sequestration in dopamine-challenged astroglia : Role of heme oxygenase-1 and the permeability transition pore |
| 000C64 |
E. M. Khalil [États-Unis] ; W. H. Ojala [États-Unis] ; A. Pradhan [Canada] ; V. D. Nair [Canada] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis] | Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide |
| 000C66 |
D. Frankel [Canada] ; H. M. Schipper [Canada] | Cysteamine pretreatment of the astroglial substratum (mitochondrial iron sequestration) enhances PC12 cell vulnerability to oxidative injury |
| 000D11 |
FENGQINSI [Canada] ; G. M. Ross [Canada] ; S. H. Shin [Canada] | Glutathione protects PC12 cells from ascorbate- and dopamine-induced apoptosis |
| 000D60 |
C.-T. Lai [Canada] ; P. H. Yu [Canada] | R(-)-deprenyl potentiates dopamine induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells |
| 000D91 |
C.-T. Lai [Canada] ; P. H. Yu [Canada] | Dopamine- and L-β-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells : effects of oxidative stress and antioxidative factors |
| 000D93 |
P. W. Baures [États-Unis] ; W. H. Ojala [États-Unis] ; W. J. Costain [Canada] ; M. C. Ott [Canada] ; A. Pradhan [Canada] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis] | Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of L-prolyl-L-leucylglycinamide |
| 000D97 |
K. B. S. Pasumarthi [Canada] ; Y. Jin [Canada] ; P. A. Cattini [Canada] | Cloning of the rat Fibroblast growth factor-2 promoter region and its response to mitogenic stimuli in glioma C6 cells |
| 000E23 |
D. Boismenu [Canada] ; O. Mamer [Canada] ; L. Ste-Marie [Canada] ; L. Vachon [Canada] ; J. Montgomery [Canada] | In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors : Electrospray-MS analysis of intra-striatal microdialysates |
| 001126 |
P. Falardeau ; S. Bouchard ; P. J. Bedard ; R. Boucher ; T. Di Paolo | Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2dopamine agonists in MPTP monkeys |
